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Crystallographic analysis of the catalytic domain of PHD ﬁnger protein 8 (PHF8), an Ne-methyl lysine
histone demethylase associated with mental retardation and cleft lip/palate, reveals a double-
stranded b-helix fold with conserved Fe(II) and cosubstrate binding sites typical of the 2-oxoglutar-
ate dependent oxygenases. The PHF8 active site is highly conserved with those of the FBXL10/
11demethylases, which are also selective for the di-/mono-methylated lysine states, but differs from
that of the JMJD2 demethylases which are selective for tri-/di-methylated states. The results ratio-
nalize the lack of activity for the clinically observed F279S PHF8 variant and they will help to identify
inhibitors selective for speciﬁc Ne-methyl lysine demethylase subfamilies.
 2010 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction central role in the hypoxic response by oxygen-dependent regula-The recognition that epigenetic regulation is important in neu-
rodegenerative disease and mental disorders is increasing [1]. His-
tone modifying enzymes, including histone deacetylases (HDACs)
and Ne-methyl lysine demethylases, are associated with brain dis-
orders [2]. Inhibitors of HDACs have potential for cancer treatment
[3], and are proposed as targets for brain diseases [4]. However, the
complexity of histone modiﬁcations means that their targeting for
the treatment of brain disorders will likely be challenging.
Ferrous iron and 2-oxoglutarate (2OG) dependent oxygenases
are an important class of enzymes involved in metabolism and
transcriptional regulation in eukaryotes [5]. Following the discov-
ery of the FAD-dependent lysine demethylases, the Jumonji do-
main containing (JmjC) family of 2OG oxygenases have emerged
as the largest identiﬁed family of identiﬁed histone Ne-methyl
lysine demethylases [6–8]. Human 2OG oxygenases also play aon behalf of the Federation of Euro
, factor inhibiting hypoxia-
, Jumonji domain; 2OG, 2-
mics Consortium, University
adington, OX3 7DQ, United
J. Schoﬁeld).
.ac.uk (C.J. Schoﬁeld), udo.tion of transcription, and catalyze modiﬁcations to N- and C-meth-
ylated nucleic acids [9–12].
The JmjC histone demethylases target all three possible Ne-
methylation states of lysine residues. There is evidence that some
JmjC demethylases have other protein substrates in addition to his-
tones [13]; other JmjC family members (as deﬁned by structure/se-
quence rather than function) catalyze asparaginyl 3-hydroxylation
of the ubiquitous ankyrin repeat domains (factor inhibiting hypox-
ia-inducible factor (FIH)) and lysine 5-hydroxylation of splicing-re-
lated proteins (JMJD6) [14,15].
The selectivity determinants for different JmjC histone demeth-
ylases include substrate primary sequence/methylation states, the
presence of targeting domains, and the presence of other post-
translational modiﬁcations. For example, the JMJD2 sub-family is
selective for the tri- and di-Ne-methylation states of histone 3 ly-
sine 9 (abbreviated as H3K9) and H3K36 [16–18]. In contrast, the
F-box and leucine rich repeat (FBXL) sub-family of histone demeth-
ylases is selective for the di- and mono-Ne-methylated states of
H3K36, but not the tri-Ne-methylated state [19,20]. To date, few
crystal structures of JmjC demethylases have been reported
(JMJD2A and FBXL11), and a molecular understanding of the se-
quence and methylation state selectivity is just emerging
[16,17,21].
Recently, plant homeo domain ﬁnger protein 8 (PHF8) has been
assigned as an Ne-methyl lysine demethylase with selectivity forpean Biochemical Societies.
Table 1
X-ray data collection and reﬁnement statistics.
Data collection
Space group I213
a = b = c (Å) 151.98
Wavelength (Å) 0.9795
Resolutiona (Å) 33.76–2.15 (2.21–2.15)
Rmerge 0.08 (0.81)
I/r(I) 16.60 (2.00)












Side-chain and water 55.61
R.m.s deviations
Bond lengths (Å) 0.008
Bond angles () 1.029
PDB-ID 2WWU
a Numbers in parentheses represent data in the highest resolution shell.
b Rfree is calculated for 5% of randomly selected reﬂections excluded from
reﬁnement.
c 7 Sulfate ions, 5 acetate ions, 2 glucose molecules.
Fig. 1. The overall structure of PHF8. (a) Stereoview ribbons representation of the PHF8 s
(orange). (b) Stereoview of the active site showing the 2OG binding pocket (2|Fo  Fc| m
(red)).
826 W.W. Yue et al. / FEBS Letters 584 (2010) 825–830di- and mono-Ne-methylation states of H3K9 and H3K36 [20].
Mutations to PHF8, including a point mutation resulting in the
F279S variant, are associated with Siderius X-linked mental retar-
dation (XLMR) syndrome (OMIM 300263), the symptoms of which
include facial dysmorphism and cleft lip/palate [22,23]. Here we
report crystallographic analyses of the PHF8 catalytic domain,
revealing signiﬁcant active site differences between the PHF/FBXL
and JMJD2 subfamilies.
2. Materials and methods
2.1. Expression and puriﬁcation
PHF8 DNA encoding for the catalytic domain (residues 79–447;
GenBank entry 32698700) was cloned into the pNH-TrxT vector
which encodes for a protein with an N-terminal His(6X)-thiore-
doxin tag followed by a TEV-protease cleavage site. PHF879-447
was expressed using Escherichia coli BL21(DE3)-R3-pRARE2, puri-
ﬁed by Ni-afﬁnity, size-exclusion and ion-exchange chromatogra-
phy and the tag removed by incubation with protease. Details of
expression and puriﬁcation procedures are included as Supple-
mentary data.
2.2. Crystallization and structure determination
Crystals were grown at 4 C by vapor diffusion in sitting drops
by mixing PHF879-447 (12 mg/ml with 2 mM N-oxalylglycine) andtructure. Active site metal coordinating residues (white) and Ni(II) (in place of Fe(II))
aps in cyan contoured to 1r, |Fo  Fc| maps contoured to 3r (dark blue) and 3r
Fig. 2. Structure-based sequence alignment of PHF8 JmjC domain with predicted members of the PHF/FBXL sub-family of histone demethylases. Conservation is indicated by
background color; blue—strictly conserved, light blue—semi-conserved, grey—some conservation, and white—non-conserved. The PHF8 secondary structure is indicated
above the sequence as a-helix (red cylinders) and b-strand (blue arrows). The double-stranded b-helix core is highlighted with cyan arrows. Red triangles indicate metal and
2OG binding residues. Green triangles indicate predicted Ne-methyl lysine interacting residues. Black boxes indicate predicted substrate recognition elements. An orange star
highlights the clinically observed F279S mutant in PHF8. RefSeq IDs are NP_055922 (PHF8), NP_005383 (PHF2), NP_085150 (JHDM1D), NP_036440 (FBXL11), and NP_115979
(FBXL10).
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pH 4.25 in a 2:1 ratio. Crystals were cryo-protected using 30% (v/
v) glucose and ﬂash-cooled in liquid nitrogen. Diffraction data
extending to 2.15 Å resolution were collected at the Diamond Light
Source beamline I02, and processed using the CCP4 program suite
[24]. PHF879–447 crystallized in the cubic space group I213 with one
molecule in the asymmetric unit. The structure was solved by
molecular replacement using the program PHASER [25] with the
human FBXL11 (JHDM1A) structure (PDB ID 2YU1) as a search
model. Automated model building was performed with BUCCA-
NEER [26], followed by iterative cycles of restrained reﬁnement
and model building using PHENIX [27] and COOT (Table 1) [28].
3. Results and discussion
3.1. Overall structure and Fe(II) and 2OG binding sites
The structure of the PHF8 catalytic domain has visible electron
density for mainchain residues 80–442 and most sidechains
(Fig. 1). The structure possesses the double-stranded b-helix
(DSBH) fold characteristic of all 2OG oxygenases studied [29]. A to-
tal of 13 b-strands make up the fold which is surrounded by 12 a-helices. The core DSBH fold is comprised of eight b-strands, four of
which (b1, b3, b6 and b8) form part of the major b-sheet with the
other four (b2, b4, b5, b7) making up the minor b-sheet. The major
b-sheet is extended at either end by an additional ﬁve N-terminal
b-strands (b1I, b1II, b1III, b1IV, b1V). The PHF8 structure is similar to
that reported for FBXL11 with an overall r.m.s.d. of 1.4 Å based on
Ca atoms for 326 matching residues [21].
The PHF8 active site is located at the ‘‘open” end of the DSBH,
strands b1 and b2, where the metal binding ligands H247, D249
and H319 (HXD. . .H motif) are located (Figs. 1b, 2 and 3). The ac-
tive site metal was modeled as Ni(II) because Ni(II) was present
during puriﬁcation. K264 extends into the deepest part of the
2OG binding pocket from strand b7 and is predicted to interact
with the 2OG C-5 carboxylate via electrostatic and hydrogen bond-
ing interactions. The 2OG C-5 carboxylate is also predicted to
hydrogen bond with the T244 sidechain hydroxyl group, as ob-
served for similarly positioned alcohols with other 2OG oxygen-
ases; Y132JMJD2A, T196FIH and T172CAS (CAS, clavaminic acid
synthase) [16,30,31]. A small amount of elongated electron density
was observed in the predicted 2OG binding pocket (Fig. 1b), but
was insufﬁcient to model NOG, a 2OG analogue and inhibitor of
PHF8 that was present in the crystallization buffer.
Fig. 3. Comparison of active sites for histone demethylases. (a) PHF8 structure (grey) with Ni(II) (orange) substituted for the Fe(II) including modeled 2OG and Y257 (green).
(b) FBXL11 active site with 2OG bound (cyan) with Fe(II) shown as orange—note the unusual conformation of 2OG (PDB ID 2YU1). (c) Superimposition of (a) and (b).
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would clash with the predicted 2OG C-1 carboxylate (assuming it
binds trans to H247) [32]. Modeling the 2OG complex, accom-
plished by rotating the Y257 Ca–Cb bond by 60 away from the
metal and then positioning 2OG like that of NOG based on the
superimposed JMJD2A structure (PDB ID 2OQ6) (Fig. 4) [16], sug-
gests that bidentate 2OG-metal coordination, as observed for other
2OG oxygenases, is reasonable. However, in FBXL11 the 2OG is re-
ﬁned with a bidentate C-1 carboxylate-metal coordination; thisarrangement contrasts with that in which one of the C-1 carboxyl-
ate oxygens and the C-2 ketone oxygen coordinate the metal, as
observed for other 2OG oxygenases [29]. The unusual 2OG coordi-
nation to Fe(II) in the FBXL11 structure could possibly reﬂect a
non-reactive conformation and/or an intermediate state.
Evidence for the potential movement of the Y257PHF8 sidechain,
comes from structural analysis of equivalent residues in the related
enzymes FBXL11 and JMJD2A. Y222FBXL11 and N198JMJD2A from the
structures of the apo-form of FBXL11 (PDB ID 2YU2) and a complex
Fig. 4. Comparison of lysine binding pockets for PHF8 and JMJD2A. (a) Structure of JMJD2A (salmon) in complex with H3K9Me3 showing tri -methyl lysine substrate bound
(yellow). (b) PHF8 (grey) with modeled 2OG and ‘‘2OG bound conformation” of Y257PHF8 (green) modeled position of 2OG based on JMJD2A. N198JMJD2A superimposed with
the JMJD2A:H3K9Me3 complex (PDB ID 2OQ6).
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conformations than those observed in the structures with metal
and/or 2OG or NOG. In both cases, one conformation places the
sidechain of Y222FBXL11/N198JMJD2A very close to the metal; the
alternate orientation, as observed e.g. in the JMJD2A:NOG complex,
places the sidechain in position to interact with the C-5 carboxyl-
ate of NOG. The substitution of a tyrosine residue in the PHF8 and
FBXL10/11 enzymes for a smaller residue in JMJD2A (N197) and
the other JMJD2 tri-Ne-methyl lysine demethylases is therefore of
potential mechanistic interest. We propose that PHF8 Y257 and
the analogous residues in related enzymes may be involved in
methylation state selectivity and regulation of (co)substrate (2OG
and/or oxygen) binding/conformation during catalysis.
Consistent with their common selectivity for the di- and mono-
Ne-methylation states, the predicted Ne-methyl-lysine binding
sites for PHF2/8, JHDM1D and FBXL10/11 are highly conserved
with a well-deﬁned deep pocket (Fig. 2). JMJD2A has a similar
pocket, which binds the methylated lysine in an extended confor-
mation. The methyl-lysine binding pockets in the PHF and JMJD2
subfamilies have some differences in primary and secondary struc-
ture. However, similar methyl-lysine binding pocket residues come
from broadly analogous parts of their structures including
Y234PHF8/Y175JMJD2A (b1), F250PHF8/D191JMJD2A (loop between b2
and b3), V255PHF8/S196JMJD2A (b3), Y257PHF8/N198JMJD2A (b3), and
G331-N333PHF8/S288-N290JMJD2A (b8) (Fig. 4). In PHF8, I191–S192
are located on a loop linking b1V and a5; in JMJD2A, the spatially
analogous residues Y175 and Y177 are located on b1, reﬂecting dif-
ferences in their methyl-lysine binding pockets.
PHF8 mutations to the Jumonji domain are linked with Siderius
X-linked mental retardation syndrome; associated clinical features
include mild facial dysmorphism and cleft lip/palate [23]. One of
these mutations, F279S [22], is located on a7 and is partially buriedin a hydrophobic pocket. The F279S variant has been shown to be
catalytically inactive towards histone peptide fragments and calf
histones, and to hinder its nuclear localization [20].
In the PHF8 catalytic domain structure, V80 is located close to
the active site opening (Fig. 1), potentially positioning the absent
N-terminal PHD ﬁnger to assist in substrate recognition. Many
PHD ﬁngers have been shown to bind K4me3 residues (e.g.,
RAG2) [34]. We found that a histone H3 fragment (residues
1–14) that was tri-methylated at K4 and di-methylated at K9
was a signiﬁcantly better substrate for PHF8 containing both
PHD and catalytic domains (residues 1–447) than PHF8 with only
the catalytic domain (residues 79–447) (Fig. S1). In the case of a
H3K9Me2 substrate, without tri-methylation at K4, there was no
signiﬁcant difference in activity between these two forms of
PHF8 [20]. The ﬁnding that demethylation of H3K9Me2 was sub-
stantially increased by longer PHF8 variants containing the PHD
ﬁnger and by using a H3 substrate tri-methylated at K4 suggests
that chromatin-binding domains play an important role in deter-
mining histone demethylase selectivity.
An insert between DSBH b-strands b4 and b5 (residues 269–
301) is positioned to be involved in substrate recognition as was
observed for JmjC family proteins FIH and JMJD2A [16,30]. In
PHF8, 3 b-strands (b1III, b1IV and b1V (residues 156–171)), likely
help to form the active site entrance and (by comparison with en-
zyme-substrate complex structures for other 2OG oxygenases)
form part of the substrate binding groove. Two other regions, res-
idues 190–199 located between b1V and a5, and residues 220–234
located between a6 and b1, are likely involved in forming the pre-
dicted substrate binding groove.
The C-terminal helices of PHF8 (a9–a12) form a four helix bun-
dle, which is important for activity; PHF81–340 lacking this region
was not active in 2OG turnover assays (Fig. S2). The crystal
830 W.W. Yue et al. / FEBS Letters 584 (2010) 825–830structures of PHF8 and FBXL11 reveal differences in the conforma-
tion of the loop linking a9 and a10, which is predicted to form part
of the substrate binding groove. The substrate binding groove in
FBXL11 is more open, whilst in PHF8 a neighboring molecule
makes crystal packing contacts with the a9–a10 loop and its sub-
strate binding groove is blocked by R360.
4. Conclusions
The combined structural studies on histone demethylases from
the JMJD2A and PHF/FBXL subfamilies have revealed highly con-
served features in terms of the Fe(II), and to a lesser extent, the
2OG and methyl-lysine binding residues. More structures for en-
zyme-substrate complexes, in addition to those reported for
JMJD2A, are required to develop a better understanding of how se-
quence selectivity is achieved. The available evidence suggests that
away from the active site there may be considerable variation
involving conformational changes in the loops surrounding the ac-
tive site and additional modular domains that contribute to the
way the different histone sequences are recognized by and bind
to the various JmjC demethylase subfamilies.
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